Side effects of COVID-19 vaccination in Pakistani population: A cross sectional study
Preprint
- 14 July 2023
- preprint
- Published by Qeios Ltd in Qeios Preprints
Abstract
_OBJECTIVES:_ Data from clinical trials around the world show that the COVID-19 vaccines are effective in terms of reducing hospitalizations need for respiratory support and deaths. However, to assess common or uncommon adverse events of the COVID-19 vaccines, data from real world experiences need to be evaluated to resolve the speculations associated with the vaccines. _MATERIALS AND METHODS:_ A questionnaire based on demographic details, vaccination details, side effects experienced, the duration of side effects and COVID-19 status was administered to study participants during this cross-sectional study. _RESULTS AND DISCUSSION:_ A total of 1162 responses were collected from fully vaccinated individuals, where Sinovac was the highly administered vaccine (40%). Most of the vaccinated participants (94%) did not contract SARS-CoV-2 infection following vaccination; however, the rate of hospitalization (4.2%) and development of extreme complications (1.4%) was lower in those who contracted the disease after vaccination compared to those who contracted COVID-19 before being fully vaccinated (7.1%). The most frequent side effects of vaccination reported were moderate pain at the site of injection administration, muscle pain, headache, fever, fatigue, swelling, redness or pain at the site of injection, nausea and joint pain. Only 2% of the participants encountered extreme daily routine difficulties while most of the side effects resolved within one week (30%). _CONCLUSION:_ The present study reports mild post vaccination side effects and low incidence of SARS-CoV-2 following COVID-19 vaccination. These results may help in improving the public perception and confidence towards COVID-19 vaccination in the Pakistani population.Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyThe Lancet, 2021
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in AdultsJAMA, 2021
- Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side EffectsVaccines, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- Acute Allergic Reactions to mRNA COVID-19 VaccinesJAMA, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Side effects after COVID-19 vaccinations among residents of Poland2021
- Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patientsInternational Journal of Chronic Obstructive Pulmonary Disease, 2017